Panitumumab triplet therapy in colorectal cancer
9 Sep 2017
Panitumumab triplet therapy in colorectal cancer
Phase Ib/II trial of combination PD-1 therapy against kidney cancer
Reviewing LORELEI, mindACT and ExteNET trials in breast cancer
PACIFIC trial of durvalumab for stage III NSCLC
ESMO 2017: CDK4/6 inhibitors from a patient’s perspective
Editor's Choice for August 2017
Editor's Choice for July 17
Emerging targets for the treatment of lung cancer
New treatment avenues in squamous cell carcinoma
New treatments for lung cancer
Lung cancer advances beyond PD1
New treatments for acute myeloid leukaemia and lymphoid leukaemia